Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 681 - 700 results of 100,378 for search '(( 50 ((ng decrease) OR (nn decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.27s Refine Results
  1. 681
    Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF-

    Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 682
    Effect of MN705 treatment on TGF-

    Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 683
    The screening process of MN705.

    The screening process of MN705. by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 684
    Changes associated with kidney fibrosis and effects of MN705 treatment on TGF-

    Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 685
    Plasmid and genomic changes detected in de-evolution trials.

    Plasmid and genomic changes detected in de-evolution trials. by Irina V. Bakhlanova (2636080)

    Published 2016
    Save to List
    Saved in:
  6. 686
    Immunoblotting for insulin sensitivity markers.

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 687
    S3 Data -

    S3 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 688
    S2 Data -

    S2 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 689
    S1 Data -

    S1 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 690
    S4 Data -

    S4 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 691
    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR.

    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 692
    Immunoblotting for JAK, STAT, and SMAD.

    Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 693
    Fibrosis and TUNEL staining.

    Fibrosis and TUNEL staining. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 694
    Fibrosis markers.

    Fibrosis markers. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 695
    Immunoblotting FOXO1 and insulin receptors.

    Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 696
    LuxR G37V has decreased DNA-binding activity.

    LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

    Published 2024
    Save to List
    Saved in:
  17. 697
    Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L<sup>-1</sup>).

    Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L<sup>-1</sup>... by Sandra Thalerová (11434762)

    Published 2024
    Save to List
    Saved in:
  18. 698
    Decrease of SRBC-specific antibody responses after <i>P</i>. <i>yoelii</i> infection.

    Decrease of SRBC-specific antibody responses after <i>P</i>. <i>yoelii</i> infection. by Simran Banga (227952)

    Published 2015
    Save to List
    Saved in:
  19. 699
    Reduction of GC B cells decreases the number of Tfh cells in NZB/W F1 mice.

    Reduction of GC B cells decreases the number of Tfh cells in NZB/W F1 mice. by Isharat Yusuf (354734)

    Published 2014
    Save to List
    Saved in:
  20. 700
    Growth disadvantage conferred by RecA D112R.

    Growth disadvantage conferred by RecA D112R. by Irina V. Bakhlanova (2636080)

    Published 2016
    Save to List
    Saved in:

Search Tools: